DK0409412T3 - Diarylether-cykliske ethere - Google Patents

Diarylether-cykliske ethere

Info

Publication number
DK0409412T3
DK0409412T3 DK90306763.5T DK90306763T DK0409412T3 DK 0409412 T3 DK0409412 T3 DK 0409412T3 DK 90306763 T DK90306763 T DK 90306763T DK 0409412 T3 DK0409412 T3 DK 0409412T3
Authority
DK
Denmark
Prior art keywords
formula
diaryl ether
cyclic ether
cyclic ethers
sulphinyl
Prior art date
Application number
DK90306763.5T
Other languages
English (en)
Inventor
Philip Neil Edwards
Thomad Geoffrey Colerick Bird
Original Assignee
Ici Plc
Ici Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc, Ici Pharma filed Critical Ici Plc
Application granted granted Critical
Publication of DK0409412T3 publication Critical patent/DK0409412T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Materials For Photolithography (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Epoxy Resins (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
DK90306763.5T 1989-07-18 1990-06-20 Diarylether-cykliske ethere DK0409412T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89402047 1989-07-18

Publications (1)

Publication Number Publication Date
DK0409412T3 true DK0409412T3 (da) 1994-10-24

Family

ID=8202978

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90306763.5T DK0409412T3 (da) 1989-07-18 1990-06-20 Diarylether-cykliske ethere

Country Status (16)

Country Link
US (1) US5137913A (da)
EP (1) EP0409412B1 (da)
JP (1) JPH0356476A (da)
AT (1) ATE108785T1 (da)
AU (1) AU630709B2 (da)
CA (1) CA2019543A1 (da)
DE (1) DE69010795T2 (da)
DK (1) DK0409412T3 (da)
ES (1) ES2056383T3 (da)
FI (1) FI903623A0 (da)
IE (1) IE902113A1 (da)
IL (1) IL94733A0 (da)
NO (1) NO903186L (da)
NZ (1) NZ234057A (da)
PT (1) PT94721A (da)
ZA (1) ZA905246B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254581A (en) * 1990-06-21 1993-10-19 Imperial Chemical Industries Plc Pyran derivatives and their use as inhibitors of 5-lipoxygenase
EP0555067A1 (en) * 1992-02-07 1993-08-11 Zeneca Limited Hydroxylamine derivatives as 5-lipoxygenase inhibitors
GB9300894D0 (en) * 1992-02-07 1993-03-10 Zeneca Ltd Oxime derivatives
CA2094465A1 (en) * 1992-04-23 1993-10-24 Pierre Andre Raymond Bruneau Cycloalkane derivatives
CA2095005A1 (en) * 1992-05-12 1993-11-13 Philip Neil Edwards Hydroxylamine derivatives
CA2095006A1 (en) * 1992-05-12 1993-11-13 Philip Neil Edwards Oxime derivatives
AU4444393A (en) * 1992-09-01 1994-03-10 Zeneca Limited Pyrrolidine derivatives
WO1994005638A1 (en) * 1992-09-02 1994-03-17 Abbott Laboratories Trans 1,4-diether cyclohexane inhibitors of 5-lipoxygenase
US5446062A (en) * 1993-11-12 1995-08-29 Abbott Laboratories ((4-alkoxypyran-4-yl) substituted) ether, arylalkyl-, arylalkenyl-, and arylalkynyl)urea inhibitors of 5-lipoxygenase
US5407959A (en) * 1993-11-12 1995-04-18 Abbott Laboratories (Trans-1,4-dialkoxycyclohexyl) substituted arylalkylaryl-arylalkenylaryl-, and arylalkynylarylurea inhibitors of 5-lipoxygenase
US5891460A (en) * 1995-06-07 1999-04-06 University Of Southern California University Park Campus Method for reducing or preventing post-surgical adhesion formation using ketotifen and analogs thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3661917A (en) * 1970-05-21 1972-05-09 Smith Kline French Lab 3-sulfonamido-4-hydroxyphenyl-2-piperidylcarbinols
US4100296A (en) * 1975-12-12 1978-07-11 Ciba-Geigy Corporation Dioxolane derivatives
FR2348205A1 (fr) * 1976-04-15 1977-11-10 France Etat Procede de preparation de la dibenzo (b,f) oxazepine -1,4
IE56702B1 (en) * 1982-12-01 1991-11-06 Usv Pharma Corp Antiinflammatory antiallergic compounds
NO174506B (no) * 1984-10-30 1994-02-07 Usv Pharma Corp Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser
US4625034A (en) * 1985-02-04 1986-11-25 Usv Pharmaceutical Corp. 1,2-Dihydro; 1,2,3,4-tetrahydro; 5,8 dihydro; and 5,6,7,8-tetrahydroquinoline derivatives
US4839369A (en) * 1985-04-16 1989-06-13 Rorer Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
EP0271287A3 (en) * 1986-12-11 1990-06-13 Merck Frosst Canada Inc. Quinoline dioic acids and amides
EP0411676B1 (de) * 1987-01-19 1994-06-15 Ciba-Geigy Ag Substituierte Dioxanderivate
US4920133A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
US4920130A (en) * 1987-11-02 1990-04-24 Rorer Pharamceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
US4920132A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
US4920131A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
US4918081A (en) * 1988-06-20 1990-04-17 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene d4
EP0349062A1 (en) * 1988-06-27 1990-01-03 Merck Frosst Canada Inc. Quinoline ether alkanoic acid
GB8927287D0 (en) * 1988-12-23 1990-01-31 Ici Plc Cyclic ether derivatives

Also Published As

Publication number Publication date
NO903186L (no) 1991-01-21
IE902113A1 (en) 1991-06-19
US5137913A (en) 1992-08-11
AU5758090A (en) 1991-01-24
EP0409412A2 (en) 1991-01-23
ATE108785T1 (de) 1994-08-15
JPH0356476A (ja) 1991-03-12
NZ234057A (en) 1993-02-25
DE69010795D1 (de) 1994-08-25
EP0409412B1 (en) 1994-07-20
IL94733A0 (en) 1991-04-15
CA2019543A1 (en) 1991-01-18
ZA905246B (en) 1991-03-27
PT94721A (pt) 1991-03-20
AU630709B2 (en) 1992-11-05
FI903623A0 (fi) 1990-07-18
ES2056383T3 (es) 1994-10-01
EP0409412A3 (en) 1991-07-24
DE69010795T2 (de) 1994-10-27
NO903186D0 (no) 1990-07-17

Similar Documents

Publication Publication Date Title
NO903185L (no) Fremgangsmaate for fremstilling av diaryleter-heterocykliske forbindelser.
NZ235016A (en) Heterocyclic 5-lipoxygenase inhibitors, preparation and pharmaceutical compositions thereof
EP0375457A3 (en) Cyclic ether derivatives
DK0409412T3 (da) Diarylether-cykliske ethere
NO174890C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive heterocykliske cykliske etere
ATE95170T1 (de) Diarylcycloalkanether.